ReadYourDNA

Fesoterodine (Toviaz)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Fesoterodine

What it is

Fesoterodine is an antimuscarinic medicine for overactive bladder: it blocks muscarinic receptors in the bladder wall, so the bladder contracts less urgently. It is used for urgency, frequent urination and leakage, and in children for bladder problems caused by nerve damage. It is sold as Toviaz.

How genes come into it

Fesoterodine is a prodrug that blood esterases turn into 5-hydroxymethyl tolterodine, the same active form tolterodine makes; that form is then broken down by CYP2D6 and CYP3A4. CYP2D6 poor metabolizers have about twice the exposure, which the US FDA lists as an effect on drug levels. Because the activation does not need CYP2D6, the effect is smaller than for tolterodine. There is no CPIC or DPWG guideline.

Published guidelines

Clinical guidelines that name a gene for Fesoterodine. They sort people into groups by the gene copies they carry.

US FDA: CYP2D6. CYP2D6 activity score 0. Data that Demonstrate a Potential Impact on Pharmacokinetic Properties Only.

What research found

Every published finding on gene variants and Fesoterodine. Upload your DNA file to see which of these rows apply to you.

Rated evidence (1 rated variant)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CYP3A4 CYP3A4*1, CYP3A4*3, CYP3A4*20, CYP3A4*22: Level 3. Metabolism/PK. 1.

Metabolism (6 findings)

Studies of how quickly the body processes this medication.

CYP2D6 CYP2D6 intermediate metabolizer: CYP2D6 intermediate metabolizer and poor metabolizer is associated with decreased clearance of fesoterodine in healthy individuals as compared to CYP2D6 normal metabolizer.

CYP2D6 CYP2D6 ultrarapid metabolizer: CYP2D6 ultrarapid metabolizer is associated with increased clearance of fesoterodine in healthy individuals as compared to CYP2D6 normal metabolizer and intermediate metabolizer and poor metabolizer.

CYP3A4 CYP3A4 intermediate metabolizer: CYP3A4 intermediate metabolizer is associated with increased clearance of fesoterodine in healthy individuals as compared to CYP3A4 normal metabolizer.

UGT1A1, UGT1A10, UGT1A3, UGT1A4, UGT1A5, UGT1A6, UGT1A7, UGT1A8, UGT1A9 rs10929302: Genotype AA is associated with increased clearance of fesoterodine in healthy individuals as compared to genotype AG.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Aciphex (PPIs)

Advair (Corticosteroid + LABA)

AeroBid (Corticosteroids)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com